Canada markets close in 21 minutes

Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.09000.0000 (0.00%)
As of 02:35PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.68M
Enterprise Value -39.31M
Trailing P/E 30.22
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.03
Enterprise Value/Revenue -1.56k
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-43.75%
S&P500 52-Week Change 326.16%
52 Week High 30.2200
52 Week Low 30.0600
50-Day Moving Average 30.0786
200-Day Moving Average 30.1123

Share Statistics

Avg Vol (3 month) 317.95k
Avg Vol (10 day) 320.23k
Shares Outstanding 574.21M
Implied Shares Outstanding 674.21M
Float 830.11M
% Held by Insiders 110.84%
% Held by Institutions 148.58%
Shares Short (May 13, 2016) 4259.38k
Short Ratio (May 13, 2016) 41.71
Short % of Float (May 13, 2016) 40.68%
Short % of Shares Outstanding (May 13, 2016) 40.59%
Shares Short (prior month Apr 15, 2016) 4298.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 15, 2019
Ex-Dividend Date 4Sept 30, 2019
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-1.45%
Return on Equity (ttm)3.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)221k
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)62.40%

Balance Sheet

Total Cash (mrq)45.99M
Total Cash Per Share (mrq)0.62
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)89.19
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)1.39M
Levered Free Cash Flow (ttm)-666.12k